Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PDE4-IN-30

Catalog No. T214347 Copy Product Info
🥰Excellent
PDE4-IN-30 is a selective PDE4 inhibitor with an IC50 of 2.7 nM for PDE4D2, targeting PDE4 through halogen bonding and metal coordination. It demonstrates at least 67 times greater selectivity for PDE4 compared to other PDE subfamilies and is applicable in research for idiopathic pulmonary fibrosis.

PDE4-IN-30

Copy Product Info
🥰Excellent
Catalog No. T214347

PDE4-IN-30 is a selective PDE4 inhibitor with an IC50 of 2.7 nM for PDE4D2, targeting PDE4 through halogen bonding and metal coordination. It demonstrates at least 67 times greater selectivity for PDE4 compared to other PDE subfamilies and is applicable in research for idiopathic pulmonary fibrosis.

PDE4-IN-30
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
PDE4-IN-30 is a selective PDE4 inhibitor with an IC50 of 2.7 nM for PDE4D2, targeting PDE4 through halogen bonding and metal coordination. It demonstrates at least 67 times greater selectivity for PDE4 compared to other PDE subfamilies and is applicable in research for idiopathic pulmonary fibrosis.
Targets&IC50
PDE4D2:2.7 nM
In vitro
PDE4-IN-30 (compound 13c), at concentrations of 5 μM to 20 μM for 48 hours, effectively inhibits TGF-β1-induced fibroblast-to-myofibroblast transition (FMT) and epithelial-mesenchymal transition (EMT) in MRC-5 and A549 cells. Additionally, it significantly suppresses TGF-β1-induced proliferation and migration of A549 cells at the same concentrations and duration. PDE4-IN-30 also demonstrates good cellular permeability and favorable drug-like properties in Caco-2 cells.
In vivo
PDE4-IN-30 (compound 13c), administered at 2.5 mg/kg via intraperitoneal injection for three weeks, has been shown to ameliorate lung fibrosis induced by Bleomycin (BLM) in C57BL/6J mice aged 6-8 weeks.
Chemical Properties
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy PDE4-IN-30 | purchase PDE4-IN-30 | PDE4-IN-30 cost | order PDE4-IN-30 | PDE4-IN-30 in vivo | PDE4-IN-30 in vitro